These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 19894640)

  • 1. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation?
    Bouin M; Lupien F; Riberdy M; Boivin M; Plourde V; Poitras P
    Neurogastroenterol Motil; 2004 Jun; 16(3):311-4. PubMed ID: 15198653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and epidemiology of functional gastrointestinal disorders.
    Corazziari E
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):613-31. PubMed ID: 15324703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
    Manabe N; Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for functional gastrointestinal disorders in children.
    Chitkara DK; Di Lorenzo C
    Curr Opin Pharmacol; 2006 Dec; 6(6):536-40. PubMed ID: 16949871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to improve drug development for functional disorders.
    Tack J; Corsetti M
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):787-96. PubMed ID: 15324714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rome III Classification of dyspepsia: will it help research?
    Talley NJ; Ruff K; Jiang X; Jung HK
    Dig Dis; 2008; 26(3):203-9. PubMed ID: 18463436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders.
    Alpers DH
    J Psychosom Res; 2008 Jun; 64(6):567-72. PubMed ID: 18501256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].
    Mazur M; Furgała A; Thor PJ
    Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?
    Cremonini F; Talley NJ
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():40-9. PubMed ID: 15521854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    Kamm MA
    Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders.
    Wilder-Smith CH
    Gut; 2011 Nov; 60(11):1589-99. PubMed ID: 21768212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study.
    Koloski NA; Jones M; Kalantar J; Weltman M; Zaguirre J; Talley NJ
    Gut; 2012 Sep; 61(9):1284-90. PubMed ID: 22234979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current medical treatments of dyspepsia and irritable bowel syndrome.
    Camilleri M; Tack JF
    Gastroenterol Clin North Am; 2010 Sep; 39(3):481-93. PubMed ID: 20951913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.